Sanofi Consumer Healthcare Intrinsic Value
Sanofi Consumer Healthcare (SANOFICONR) median intrinsic value is ₹1681.35 from 9 valuation models (range ₹935–₹2337), vs current price ₹4674.70 — -64.0% downside (Trading Above Calculated Value), margin of safety -100.0%. Read SANOFICONR dividend payout details for the complete payout history and dividend yield track record.
SANOFICONR Valuation Methods Summary — DCF, Graham Number & P/E
Sanofi Consumer Healthcare intrinsic value across 9 models vs current price ₹4674.70 — upside/downside and value range per method. For current market price and key ratios, visit Sanofi Consumer Healthcare share price chart.
| Method | Type | Intrinsic Value | Range | Upside/Downside | Details |
|---|---|---|---|---|---|
| P/E Based Valuation | earnings | ₹2293.94 | ₹1835.15 - ₹2752.73 | -50.9% | EPS: ₹104.27, Sector P/E: 22x |
| Book Value Method | asset | ₹934.94 | ₹841.45 - ₹1028.43 | -80.0% | Book Value/Share: ₹166.96, P/B: 2.0x |
| Revenue Multiple Method | revenue | ₹1402.41 | ₹1262.17 - ₹1542.65 | -70.0% | Revenue/Share: ₹390.00, P/S: 2.0x |
| EBITDA Multiple Method | earnings | ₹1869.88 | ₹1682.89 - ₹2056.87 | -60.0% | EBITDA: ₹327.00Cr, EV/EBITDA: 10x |
| Simple DCF (5Y) | dcf | ₹1869.88 | ₹1495.90 - ₹2243.86 | -60.0% | CF Growth: 5.0%, Discount: 15% |
| PEG Ratio Method | growth | ₹1668.32 | ₹1501.49 - ₹1835.15 | -64.3% | EPS Growth: 20.0%, Fair P/E: 16.0x |
| Growth Adjusted P/E | growth | ₹1681.35 | ₹1513.21 - ₹1849.49 | -64.0% | Revenue Growth: 15.0%, Adj P/E: 16.1x |
| ROE Based Valuation | profitability | ₹2337.35 | ₹2103.61 - ₹2571.09 | -50.0% | ROE: 62.5%, P/E Multiple: 16x |
| Graham Defensive Method | conservative | ₹1402.41 | ₹1262.17 - ₹1542.65 | -70.0% | EPS: ₹104.27, BVPS: ₹166.96 |
SANOFICONR Intrinsic Value vs Market Price — All Valuation Models
Sanofi Consumer Healthcare fair value range ₹935–₹2337 vs current market price ₹4674.70 across 9 valuation models. Analyse SANOFICONR institutional holdings to track promoter, FII and institutional holdings.
SANOFICONR Intrinsic Value Analysis — Undervalued or Overvalued?
Sanofi Consumer Healthcare median intrinsic value ₹1681.35, current price ₹4674.70 — Trading Above Calculated Value by 64.0%, margin of safety -100.0%.
What is the intrinsic value of SANOFICONR?
Based on our comprehensive analysis using 9 different valuation methods, the estimated intrinsic value of Sanofi Consumer Healthcare (SANOFICONR) is ₹1681.35 (median value). With the current market price of ₹4674.70, this represents a -64.0% variance from our estimated fair value.
The valuation range spans from ₹934.94 to ₹2337.35, indicating ₹934.94 - ₹2337.35.
Is SANOFICONR undervalued or overvalued?
Based on our multi-method analysis, Sanofi Consumer Healthcare (SANOFICONR) appears to be trading above calculated value by approximately 64.0%.
SANOFICONR Financial Health — Key Ratios vs Industry Benchmarks
Sanofi Consumer Healthcare financial ratios — ROE, debt-to-equity, profit margins and liquidity vs industry benchmarks and their impact on intrinsic value.
| Financial Metric | Current Value | Industry Benchmark | Assessment | Impact on Valuation |
|---|---|---|---|---|
| Current Ratio | 14.11 | Industry Standard: 2.0+ | Above 2.0 | Measures short-term liquidity capacity |
| Return on Equity | 62.5% | Industry Standard: 15%+ | Above 15% | Measures shareholder return efficiency |
| Operating Margin | 35.0% | Industry Standard: 20%+ | Above 20% | Indicates operational efficiency level |
| Asset Turnover Ratio | 1.64x | Industry Standard: 1.0x+ | Above 1.0x | Measures asset utilization efficiency |
SANOFICONR Cash Flow Quality — Operating & Free Cash Flow
Sanofi Consumer Healthcare operating cash flow, free cash flow, quality rating and sustainability score by period — key inputs to DCF intrinsic value calculation.
| Period | Operating Cash Flow | Free Cash Flow | Cash Flow Quality | Sustainability Score |
|---|---|---|---|---|
| March 2025 | ₹175 Cr | ₹175 Cr | Positive Free Cash Flow | 8/10 |
| March 2024 | ₹439 Cr | ₹439 Cr | Positive Free Cash Flow | 8/10 |
| March 2023 | ₹0 Cr | ₹0 Cr | Negative Cash Flow | 3/10 |